Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Catridecacog (rys)

Australian Public Assessment Report

AusPAR

AusPAR: Catridecacog (rys) [PDF, 1.99 MB]

AusPAR: Catridecacog (rys) [Word, 2.67 MB]

Attachment: Product Information: Catridecacog (rys) [PDF, 232.91 KB]

Attachment: Product Information: Catridecacog (rys) [Word, 406.02 KB]

Attachment: Extract from Clinical Evaluation Report: Catridecacog (rys) [PDF, 3.5 MB]

Attachment: Extract from Clinical Evaluation Report: Catridecacog (rys) [Word, 3.74 MB]

Device/Product Name

NovoThirteen

Active ingredients

Catridecacog (rys)

AusPAR Date

10 April 2014

Published

12 June 2014

Submission Number

PM-2012-02713-3-4

Submission Type

New chemical (biological) entity

Decision

Approved